A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson’s disease: a study protocol for a randomised controlled trial

BACKGROUND: Parkinson’s disease (PD) affects approximately 145,519 people in the UK. Speech impairments are common with a reported prevalence of 68%, which increase physical and mental demands during conversation, reliance on family and/or carers, and the likelihood of social withdrawal reducing qua...

Descripción completa

Detalles Bibliográficos
Autores principales: Sackley, C. M., Rick, C., Au, P., Brady, M. C., Beaton, G., Burton, C., Caulfield, M., Dickson, S., Dowling, F., Hughes, M., Ives, N., Jowett, S., Masterson-Algar, P., Nicoll, A., Patel, S., Smith, C. H., Woolley, R., Clarke, C. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251680/
https://www.ncbi.nlm.nih.gov/pubmed/32460885
http://dx.doi.org/10.1186/s13063-020-04354-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251680/
https://www.ncbi.nlm.nih.gov/pubmed/32460885
http://dx.doi.org/10.1186/s13063-020-04354-7

Ejemplares similares